NHS (Neuberger High Yield Strategies Fund Inc.) Stock Analysis - Financials

Neuberger High Yield Strategies Fund Inc. (NHS) is a publicly traded Financial Services sector company. As of May 21, 2026, NHS trades at $6.25 with a market cap of $197.31M and a P/E ratio of 0.00. NHS moved +0.56% today. Year to date, NHS is -15.88%; over the trailing twelve months it is -16.56%. Its 52-week range spans $6.13 to $8.67. Rallies surfaces NHS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are NHS's key financials?

NHS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NHS recently traded at $6.25. Market cap is $197.31M. P/E ratio is 0.00. Revenue is $0.

NHS Key Metrics

Key financial metrics for NHS
MetricValue
Price$6.25
Market Cap$197.31M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.09%
52-Week High$8.67
52-Week Low$6.13
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest NHS News

Recent NHS Insider Trades

  • Kocinski Chris bought 6.00K (~$44.40K) on Jul 17, 2025.
  • Kocinski Chris bought 15.00K (~$111.60K) on May 29, 2025.
  • Lind Joseph bought 5.00K (~$45.71K) on Jun 7, 2022.

NHS Analyst Consensus

NHS analyst coverage data. Average price target: $0.00.

Common questions about NHS

What are NHS's key financials?
NHS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NHS recently traded at $6.25. Market cap is $197.31M. P/E ratio is 0.00. Revenue is $0.
Is NHS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NHS. It does not provide personalized investment advice.
NHS

NHS